UOC
CCXI

UBS O'Connor’s ChemoCentryx, Inc. CCXI Stock Holding History

UBS O'Connor’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,730,923
Closed -$141M – 897
2022
Q3 		$141M Buy
+2,730,923
New +$113M 1.6% 14

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS O'Connor's CCXI Position: Q4 2022 in Review

UBS O'Connor sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 2,730,923 shares — an estimated $141M sold.

UBS O'Connor first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $141M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • UBS O'Connor reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 2,730,923 ChemoCentryx, Inc. shares in Q4 2022, an estimated $141M.
  • UBS O'Connor first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • UBS O'Connor's ChemoCentryx, Inc. position peaked at $141M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.